RxDoctor Payments Data

Lisa Helmick, DO

Obstetrics & Gynecology · Bloomfield Hills, MINPI 1265624050

Payments from drug & device makers

$1,643in general payments, 2019–2025

Across 73 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$395
  • Hologic Sales And Service, LLC$204
  • Gynesonics, Inc.$125
  • Pfizer$88
  • Mayne Pharma Commercial LLC$85
  • Astellas Pharma US Inc$76
  • plus $670 from 16 others

What the payments were for

  • Food & beverage$1,643100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,643 in reported general payments places this provider in the 75th percentile of 1,474 obstetrics & gynecology providers in Michigan.

See all obstetrics & gynecology providers in Michigan

Medicare billing

Part B allowed, 2024
$28,817
Medicare patients
180
Services billed
377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron20$18,160
Mirabegron ErMirabegron13$9,236
Estradiol135$6,853
PremarinEstrogens, Conjugated11$5,066
Raloxifene Hcl24$1,219
ValacyclovirValacyclovir Hcl27$793
Clobetasol Propionate38$474
Medroxyprogesterone Acetate28$396
Oxybutynin Chloride ErOxybutynin Chloride12$262
Sumatriptan Succinate11$157
Sertraline Hcl15$145
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$134
Zolpidem Tartrate11$126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$76$18,16020 claims
PfizerPremarin$88$5,06611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,474 obstetrics & gynecology providers in Michigan.

Other obstetrics & gynecology in Bloomfield Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →